The second installment of the UroPrecision special issue, “Precision medicine in reproductive and sexual dysfunction: Tailoring treatments for optimal outcomes,” turns its focus more specifically to male infertility, a complex condition increasingly benefitting from precision-based interventions. This collection highlights how individualized care strategies—leveraging microsurgical innovations, molecular diagnostics, regenerative medicine, and artificial intelligence—are transforming the field. By prioritizing patient-specific etiologies, these studies demonstrate how precision medicine is improving outcomes and advancing our understanding of male reproductive and sexual health.
Nasrallah et al.[
1] explore “Artificial intelligence and varicocelectomy” in their forward-thinking contribution. They describe the emerging role of artificial intelligence (AI) in surgical planning, intraoperative decision-making, and outcome prediction in varicocele repair. The authors outline how AI-driven modeling can reduce recurrence rates and optimize fertility outcomes, marking an exciting convergence of technology and andrology.
Eissa et al.[
2] provide a focused review on isolated asthenozoospermia (iASZ), highlighting its multifactorial etiology including mitochondrial dysfunction, oxidative stress, and structural flagellar defects. The article underscores current diagnostic approaches and emphasizes the role of tailored interventions—ranging from lifestyle changes to assisted reproductive technologies (ART)—in managing iASZ. Their work reinforces the importance of precision-based strategies in addressing sperm motility disorders.
Saad et al.[
3] provide a comprehensive review titled “Emerging trends in the management of non-obstructive azoospermia.” The manuscript explores novel diagnostic and prognostic biomarkers, including seminal plasma proteins and miRNA profiles, along with genetic techniques such as whole-exome sequencing. Their discussion affirms that integrating genomic data with clinical algorithms can significantly improve the accuracy of sperm retrieval predictions and personalize fertility care.
Ragheb's narrative review[
4], “Intracavernosal platelet-rich plasma therapy for erectile dysfunction,” synthesizes the growing body of evidence on regenerative therapies. He identifies a need for standardization across protocols, patient selection, and platelet-rich plasma (PRP) preparation methods. The article calls for robust, multicenter randomized controlled trials (RCTs) to ensure reproducibility and translate PRP therapy into mainstream use, emphasizing how innovation must be matched by scientific rigor.
Khalafalla et al.[
5], in their study on “Surgical outcomes in male reconstructive urology,” present focused data on microsurgical vasoepididymostomy (VE) and vasovasostomy (VV) for the management of obstructive azoospermia (OA). For VE, success was more variable and technique-dependent, with bilateral intussusception showing superior outcomes compared to fistula methods. These results highlight the critical importance of advanced microsurgical skills, individualized surgical planning, and region-specific considerations, such as the prevalence of idiopathic and infection-related OA in the Middle East. The study underscores the value of personalized preoperative counseling and the need for tailored approaches to optimize fertility outcomes.
Finally, in “Effect of hormonal therapy on satisfaction rates after penile prosthesis surgery in prostate cancer survivors,” Jacob et al.[
6] assess how prior exposure to androgen deprivation therapy (ADT) may influence post-surgical satisfaction. This notable study found that men who received ADT were more likely to report lower satisfaction scores, suggesting that hormonal history must be factored into preoperative counseling. This work emphasizes that precision medicine extends beyond procedural success to include psychological and hormonal contexts.
This issue not only celebrates technological advancements but also highlights the authors’ dedication to improving patient-centered outcomes through scientific inquiry and innovation. By integrating advanced technologies and personalized strategies into clinical practice, these studies present a compelling vision of how precision medicine is reshaping male reproductive care—transforming individualized care into the new standard.
2025 The Author(s). UroPrecision published by John Wiley & Sons Australia, Ltd on behalf of Higher Education Press.
PDF
(71KB)
